![Da Qing Cai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Da Qing Cai
Eerdere bekende functies van Da Qing Cai
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Directeur/Bestuurslid | 20-08-2020 | 23-03-2023 |
Independent Dir/Board Member | 20-08-2020 | 23-03-2023 | |
BIONANO GENOMICS, INC. | Directeur/Bestuurslid | 01-08-2018 | 01-08-2019 |
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Directeur/Bestuurslid | 01-06-2016 | 01-03-2019 |
BERRY GENOMICS CO.,LTD | Directeur/Bestuurslid | 01-07-2017 | 01-04-2018 |
Opleiding van Da Qing Cai
University of Science & Technology of China | Undergraduate Degree |
Yale University | Graduate Degree |
University of California, Berkeley | Doctorate Degree |
Statistieken
Internationaal
China | 4 |
Verenigde Staten | 4 |
Kaaimaneilanden | 2 |
Operationeel
Director/Board Member | 4 |
Independent Dir/Board Member | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
BERRY GENOMICS CO.,LTD | Health Technology |
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
BIONANO GENOMICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Beurs
- Insiders
- Da Qing Cai
- Ervaring